Breaking News

Lilly Acquires Manufacturing Facility from Nexus Pharmaceuticals

Will further expand Lilly's global parenteral product manufacturing network and support increased demand for its medicines.

Author Image

By: Charlie Sternberg

Associate Editor

Eli Lilly and Company has agreed to acquire a manufacturing facility from Nexus Pharmaceuticals, a leading sterile manufacturer in the pharmaceutical industry.   The acquisition of this FDA-approved facility in Pleasant Prairie, Wisconsin will further expand Lilly’s global parenteral (injectable) product manufacturing network and support increased demand for the company’s medicines. Lilly estimates that production at this facility could begin at the end of 2025.   “The acquisitio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters